Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.

Zhang J, Wang L, Anderson LB, Witthuhn B, Xu Y, Lü J.

Cancer Prev Res (Phila). 2010 Aug;3(8):994-1006. doi: 10.1158/1940-6207.CAPR-09-0261. Epub 2010 Jul 20.

PMID:
20647336
[PubMed - indexed for MEDLINE]
2.

Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.

Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, Zhang Y, Liao JD, Cleary MP, Lü J.

Cancer Prev Res (Phila). 2009 May;2(5):484-95. doi: 10.1158/1940-6207.CAPR-08-0173. Epub 2009 Apr 28.

PMID:
19401524
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.

Zhang J, Wang L, Li G, Anderson LB, Xu Y, Witthuhn B, Lü J.

Nutr Cancer. 2011;63(5):778-89. doi: 10.1080/01635581.2011.563029. Epub 2011 Jun 1.

PMID:
21614726
[PubMed - indexed for MEDLINE]
4.

Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.

Wang L, Zhang J, Zhang Y, Nkhata K, Quealy E, Liao JD, Cleary MP, Lü J.

Prostate. 2011 Sep 15;71(13):1429-40. doi: 10.1002/pros.21360. Epub 2011 Feb 25.

PMID:
21360561
[PubMed - indexed for MEDLINE]
5.

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

Li GX, Lee HJ, Wang Z, Hu H, Liao JD, Watts JC, Combs GF Jr, Lü J.

Carcinogenesis. 2008 May;29(5):1005-12. doi: 10.1093/carcin/bgn007. Epub 2008 Feb 28.

PMID:
18310093
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.

Narayanan BA, Narayanan NK, Pittman B, Reddy BS.

Clin Cancer Res. 2004 Nov 15;10(22):7727-37.

PMID:
15570007
[PubMed - indexed for MEDLINE]
Free Article
7.

Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.

Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.

Cancer Res. 2000 Sep 15;60(18):5125-33.

PMID:
11016639
[PubMed - indexed for MEDLINE]
Free Article
8.

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.

Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H.

Cancer Res. 2004 May 1;64(9):3334-43.

PMID:
15126378
[PubMed - indexed for MEDLINE]
Free Article
9.

Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.

Cho SD, Jiang C, Malewicz B, Dong Y, Young CY, Kang KS, Lee YS, Ip C, Lü J.

Mol Cancer Ther. 2004 May;3(5):605-11.

PMID:
15141018
[PubMed - indexed for MEDLINE]
Free Article
10.

Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

Wang Z, Lee HJ, Chai Y, Hu H, Wang L, Zhang Y, Jiang C, Lü J.

Curr Cancer Drug Targets. 2010 May;10(3):307-18.

PMID:
20370687
[PubMed - indexed for MEDLINE]
11.

Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.

Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.

J Urol. 2005 May;173(5):1778-83.

PMID:
15821586
[PubMed - indexed for MEDLINE]
12.

Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.

Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S.

Prostate. 2005 Aug 1;64(3):224-39.

PMID:
15712212
[PubMed - indexed for MEDLINE]
13.

Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.

Jeet V, Ow K, Doherty E, Curley B, Russell PJ, Khatri A.

Prostate. 2008 Apr 1;68(5):548-62. doi: 10.1002/pros.20714.

PMID:
18247402
[PubMed - indexed for MEDLINE]
14.

The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.

Cancer Res. 1999 May 1;59(9):2203-9.

PMID:
10232609
[PubMed - indexed for MEDLINE]
Free Article
15.

Immunization against luteinizing hormone-releasing hormone fusion proteins does not decrease prostate cancer in the transgenic adenocarcinoma mouse prostate model.

Hill RE, de Avila DM, Bertrand KP, Greenberg NM, Reeves JJ.

Exp Biol Med (Maywood). 2003 Jul;228(7):818-22.

PMID:
12876301
[PubMed - indexed for MEDLINE]
16.

Androgen-independent prostate cancer progression in the TRAMP model.

Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM.

Cancer Res. 1997 Nov 1;57(21):4687-91.

PMID:
9354422
[PubMed - indexed for MEDLINE]
Free Article
17.

Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.

Drake EN.

Med Hypotheses. 2006;67(2):318-22. Epub 2006 Mar 30.

PMID:
16574336
[PubMed - indexed for MEDLINE]
18.

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803.

PMID:
18668517
[PubMed - indexed for MEDLINE]
19.

Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.

Jiang C, Wang Z, Ganther H, Lü J.

Mol Cancer Ther. 2002 Oct;1(12):1059-66.

PMID:
12481429
[PubMed - indexed for MEDLINE]
Free Article
20.

Genistein alters growth factor signaling in transgenic prostate model (TRAMP).

Wang J, Eltoum IE, Lamartiniere CA.

Mol Cell Endocrinol. 2004 Apr 30;219(1-2):171-80.

PMID:
15149738
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk